The Dermatology Digest

DECEMBER 21, 2023

The two distribution agreements for the Evolysse /Estyme fillers portfolio will grant Evolus the ability to offer filler solutions to cover mid-face, nasolabial folds, and lip indications in Europe plus an eye product line in the U.S. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36

The Dermatology Digest

DECEMBER 21, 2023

The two distribution agreements for the Evolysse /Estyme fillers portfolio will grant Evolus the ability to offer filler solutions to cover mid-face, nasolabial folds, and lip indications in Europe plus an eye product line in the U.S. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36

Aesthetics Advisor

SEPTEMBER 15, 2023

Glenmark Pharmaceuticals has signed a partnership with Canadian company SaNOtize Research & Development Corp., For a full list of Marinomed’s portfolio of Carragelose® containing nasal sprays and oral products, please visit [link] , for a list of scientific publications on Carragelose®, [link].

Hospital 69

Hospital Clinic Marketing Medical 69